Back to results
US 2012/0071333 A1Published application
Uses of systems with degrees of freedom poised between fully quantum and fully classical states
AssigneesTampere University of Technology, University of Vermont
InventorsStuart Kauffman, Samuli Niiranen, Gábor Vattay
Life of this patent
Estimating the term…
Abstract
Disclosed herein are systems and uses of systems operating between fully quantum coherent and fully classical states. Such systems operate in what is termed the “Poised realm” and exhibit unique behaviors that can be applied to a number of useful applications. Non-limiting examples include drug discovery, computers, and artificial intelligence
Claims62
A quantum reservoir computer, comprising:
- a plurality of nodes, each node comprising at least one quantum degree of freedom that is coupled to at least one quantum degree of freedom in each other node;
- at least one input signal generator configured to produce at least one time-varying input signal that couples to said quantum degree of freedom;
- and
- a detector configured to receive a plurality of time-varying output signals that couple to said quantum degree of freedom.
1 more element
A method of drug discovery, comprising:
- selecting a biological target;
- screening a library of candidate molecules to identify a first subset of candidate molecules that bind to the biological target;
- determining the energy level spacing distribution of a quantum degree of freedom in each of the candidate molecules in the first subset;
- comparing the energy level spacing distribution to at least one pre-determined reference function;
- and
- selecting a second subset of molecules from the first subset as drug candidates based on the comparison.
3 more elements
A method of drug discovery, comprising:
- selecting a biological target;
- screening a library of candidate molecules to identify a first subset of candidate molecules that bind to the biological target;
- determining the energy level spacing distribution of a quantum degree of freedom in each of the candidate molecules in the first subset;
- conducting an in vitro or in vivo assay for biological activity on each of the candidate molecules in the first subset;
- correlating the energy level spacing distribution with activity determined from the in vitro or in vivo assay;
- determining the energy level spacing distributions of a quantum degree of freedom in a new set of candidate molecules;
- comparing the energy level spacing distributions of the new set of candidate molecules with energy level spacing distributions that correlate with biological activity;
- and
- select as drug candidates from the new set of candidate molecules those molecules whose energy level spacing distributions exhibit a pre-determined level of similarity to the energy level spacing distributions that correlate with biological activity.
6 more elements
A method of drug discovery, comprising:
- selecting a biological target;
- screening a library of candidate molecules to identify a first subset of candidate molecules that bind to the biological target;
- measuring decoherence decay of a quantum degree of freedom in each of the candidate molecules in the first subset;
- comparing the decoherence decay to at least one pre-determined reference function;
- and
- selecting a second subset of molecules from the first subset as drug candidates based on the comparison.
3 more elements
A method of drug discovery, comprising:
- selecting a biological target;
- screening a library of candidate molecules to identify a first subset of candidate molecules that bind to the biological target;
- measuring decoherence decay of a quantum degree of freedom in each of the candidate molecules in the first subset;
- conducting an in vitro or in vivo assay for biological activity on each of the candidate molecules in the first subset;
- correlating the decoherence decay with activity determined from the in vitro or in vivo assay;
- measuring decoherence decay of a quantum degree of freedom in a new set of candidate molecules;
- comparing the decoherence decay of the new set of candidate molecules with the decoherence decay that correlate with biological activity;
- and
- select as drug candidates from the new set of candidate molecules those molecules whose decoherence decay exhibit a pre-determined level of similarity to the decoherence decay that correlate with biological activity.
6 more elements
A Trans-Turing machine, comprising:
- a plurality of nodes, each node comprising at least one quantum degree of freedom that is coupled to at least one quantum degree of freedom in another node and at least one classical degree of freedom that is coupled to at least one classical degree of freedom in another node, wherein the nodes are configured such that the quantum degrees of freedom decohere to classicity and thereby alter the classical degrees of freedom, which then alter the decoherence rate of remaining quantum degrees of freedom;
- at least one input signal generator configured to produce an input signal that recoheres classical degrees of freedom to quantum degrees of freedom;
- and
- a detector configured to receive quantum or classical output signals from the nodes.
1 more element
A method of measuring the state of a physical system, comprising:
- determining the degree of quantum coherence of at least one degree of freedom in the system;
- determining the degree of order of the system;
- and
- classifying the system based on the determined degree of quantum coherence and the determined degree of order.
1 more element
Dependencies are inferred from the claim text.